Argenica Therapeutics Limited (AGN.AX)
AUD 0.62
(-3.13%)
AUD 0.62
(-3.13%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -15.91 Million AUD | -71.3% |
| 2023 | -9.28 Million AUD | -4.2% |
| 2022 | -8.91 Million AUD | -24.78% |
| 2021 | -7.14 Million AUD | -1989.04% |
| 2020 | -341.98 Thousand AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -15.91 Million AUD | -88.81% |
| 2024 Q4 | -15.91 Million AUD | 0.0% |
| 2024 Q1 | -8.42 Million AUD | 5.46% |
| 2024 FY | -15.91 Million AUD | -71.3% |
| 2024 Q2 | -8.42 Million AUD | 0.0% |
| 2023 Q3 | -9.28 Million AUD | -14.29% |
| 2023 FY | -9.28 Million AUD | -4.2% |
| 2023 Q2 | -8.12 Million AUD | 0.0% |
| 2023 Q1 | -8.12 Million AUD | 8.83% |
| 2023 Q4 | -8.91 Million AUD | 4.03% |
| 2022 Q4 | -8.91 Million AUD | 0.0% |
| 2022 Q1 | -5.3 Million AUD | 25.72% |
| 2022 Q3 | -8.91 Million AUD | -67.99% |
| 2022 FY | -8.91 Million AUD | -24.78% |
| 2022 Q2 | -5.3 Million AUD | 0.0% |
| 2021 Q3 | -7.14 Million AUD | -484.85% |
| 2021 FY | -7.14 Million AUD | -1989.04% |
| 2021 Q4 | -7.14 Million AUD | 0.0% |
| 2021 Q2 | -1.22 Million AUD | 0.0% |
| 2021 Q1 | -1.22 Million AUD | -257.19% |
| 2020 Q4 | -341.98 Thousand AUD | 0.0% |
| 2020 FY | -341.98 Thousand AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | -18.89 Million AUD | 15.8% |
| Anatara Lifesciences Ltd | -982.1 Thousand AUD | -1520.257% |
| Zelira Therapeutics Limited | 5.06 Million AUD | 414.024% |
| Biome Australia Limited | -1.56 Million AUD | -918.21% |
| Patrys Limited | -2.24 Million AUD | -610.177% |
| Orthocell Limited | -19.92 Million AUD | 20.136% |
| Imugene Limited | -91.56 Million AUD | 82.621% |
| Noxopharm Limited | -2.31 Million AUD | -585.912% |
| PYC Therapeutics Limited | -65.76 Million AUD | 75.803% |
| Chimeric Therapeutics Limited | -3.05 Million AUD | -421.214% |
| Prescient Therapeutics Limited | -10.16 Million AUD | -56.579% |
| Proteomics International Laboratories Limited | -6.32 Million AUD | -151.629% |
| Cynata Therapeutics Limited | -6.2 Million AUD | -156.432% |
| CSL Limited | 15.76 Billion AUD | 100.101% |
| Arovella Therapeutics Limited | -12.71 Million AUD | -25.155% |
| Bio-Gene Technology Limited | -709.55 Thousand AUD | -2142.616% |
| Clinuvel Pharmaceuticals Limited | -182.98 Million AUD | 91.304% |
| Starpharma Holdings Limited | -19.83 Million AUD | 19.763% |
| Nanollose Limited | -96.22 Thousand AUD | -16436.929% |
| Memphasys Limited | 4.13 Million AUD | 484.794% |
| Invex Therapeutics Ltd | -6.02 Million AUD | -164.108% |
| NeuroScientific Biopharmaceuticals Limited | -4.95 Million AUD | -221.199% |
| Amplia Therapeutics Limited | -1.82 Million AUD | -772.6% |
| Botanix Pharmaceuticals Limited | -79.3 Million AUD | 79.936% |
| Island Pharmaceuticals Limited | -1.23 Million AUD | -1184.928% |
| Race Oncology Limited | -17.18 Million AUD | 7.424% |
| Nyrada Inc. | -4.76 Million AUD | -233.643% |
| Telix Pharmaceuticals Limited | -105.79 Million AUD | 84.959% |
| Dimerix Limited | -21.99 Million AUD | 27.643% |
| PharmAust Limited | -9.71 Million AUD | -63.81% |
| Immutep Limited | -122.18 Million AUD | 86.977% |
| Clarity Pharmaceuticals Ltd | -136.5 Million AUD | 88.343% |
| Alterity Therapeutics Limited | -12.47 Million AUD | -27.507% |
| BTC Health Limited | -2.02 Million AUD | -686.916% |
| Acrux Limited | -1.45 Million AUD | -991.403% |
| Neuren Pharmaceuticals Limited | -17.09 Million AUD | 6.911% |
| Biotron Limited | -386.06 Thousand AUD | -4021.725% |
| Tissue Repair Ltd | -16.44 Million AUD | 3.214% |
| AdAlta Limited | -845.17 Thousand AUD | -1782.77% |
| Radiopharm Theranostics Limited | -18.57 Million AUD | 14.333% |
| Hexima Limited | -2.22 Million AUD | -614.786% |
| AnteoTech Limited | -5 Million AUD | -218.156% |
| Paradigm Biopharmaceuticals Limited | -17.58 Million AUD | 9.492% |
| Recce Pharmaceuticals Ltd | -3.39 Million AUD | -368.552% |
| Avecho Biotechnology Limited | -5.32 Million AUD | -198.591% |
| Actinogen Medical Limited | -9.13 Million AUD | -74.258% |
| Immuron Limited | -11.48 Million AUD | -38.566% |